FDA Rejects Johnson & Johnson's RA Drug Sirukumab, More Safety Data Needed – biolegacy

FDA Rejects Johnson & Johnson's RA Drug Sirukumab, More Safety Data Needed

Post author:Sam
Post published:September 24, 2017
Post category:BioPharma

September 25, 2017By Alex Keown, BioSpace.com Breaking…
Source: BioSpace